
Centennial Surgical (CSURGSU) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
133.1M
Gross Profit
97.7M
73.40%
Operating Income
8.0M
6.05%
Net Income
-11.8M
-8.89%
Balance Sheet Metrics
Total Assets
845.8M
Total Liabilities
538.3M
Shareholders Equity
307.5M
Debt to Equity
1.75
Cash Flow Metrics
Revenue & Profitability Trend
Centennial Surgical Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 535.2M | 511.9M | 526.6M | 444.3M | 369.3M |
Cost of Goods Sold | 172.3M | 173.0M | 202.3M | 198.0M | 105.9M |
Gross Profit | 362.9M | 338.9M | 324.3M | 246.2M | 263.5M |
Gross Margin % | 67.8% | 66.2% | 61.6% | 55.4% | 71.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 14.9M | 15.8M | 10.6M | 14.5M |
Other Operating Expenses | 181.7M | 158.9M | 152.3M | 82.8M | 97.8M |
Total Operating Expenses | 181.7M | 173.8M | 168.1M | 93.4M | 112.3M |
Operating Income | 20.1M | 37.6M | 31.0M | 29.6M | 35.5M |
Operating Margin % | 3.8% | 7.4% | 5.9% | 6.7% | 9.6% |
Non-Operating Items | |||||
Interest Income | - | 803.0K | 111.0K | 83.0K | 59.0K |
Interest Expense | 37.5M | 9.3M | 7.0M | 7.6M | 9.7M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -16.2M | 12.7M | 14.6M | 10.7M | 15.3M |
Income Tax | -1.5M | 1.4M | 5.8M | 4.5M | 5.7M |
Effective Tax Rate % | 0.0% | 10.9% | 39.4% | 41.6% | 37.1% |
Net Income | -14.6M | 11.3M | 8.9M | 6.3M | 9.6M |
Net Margin % | -2.7% | 2.2% | 1.7% | 1.4% | 2.6% |
Key Metrics | |||||
EBITDA | 63.8M | 35.9M | 34.6M | 33.7M | 40.5M |
EPS (Basic) | - | ₹3.11 | ₹2.43 | ₹1.72 | ₹2.64 |
EPS (Diluted) | - | ₹3.11 | ₹2.43 | ₹1.72 | ₹2.64 |
Basic Shares Outstanding | - | 3648300 | 3648300 | 3648300 | 3648300 |
Diluted Shares Outstanding | - | 3648300 | 3648300 | 3648300 | 3648300 |
Income Statement Trend
Centennial Surgical Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 2.2M | 6.8M | 3.3M | 2.6M | 5.4M |
Short-term Investments | - | - | - | 5.0K | 69.0K |
Accounts Receivable | 184.0M | 188.0M | 205.9M | 195.3M | 224.0M |
Inventory | 434.8M | 425.2M | 372.4M | 322.6M | 362.3M |
Other Current Assets | 8.7M | 1.0K | 12.0M | -1.0K | 4.6M |
Total Current Assets | 629.6M | 653.2M | 593.7M | 532.7M | 606.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 199.8M | 127.7M | 64.6M | 76.0M | 89.7M |
Goodwill | 42.0K | 52.0K | 43.0K | 34.0K | 70.0K |
Intangible Assets | 42.0K | 52.0K | 43.0K | 34.0K | 70.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 2.6M | -1.0K | 1.4M | 1.0K | 1.4M |
Total Non-Current Assets | 216.2M | 138.3M | 70.3M | 80.7M | 94.3M |
Total Assets | 845.8M | 791.5M | 664.0M | 613.4M | 700.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 71.7M | 97.1M | 122.3M | 85.6M | 105.8M |
Short-term Debt | 122.6M | 153.0M | 106.3M | 99.1M | 128.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 62.2M | 28.8M | 28.8M | 28.8M | 4.4M |
Total Current Liabilities | 318.3M | 328.5M | 290.7M | 242.0M | 315.0M |
Non-Current Liabilities | |||||
Long-term Debt | - | 123.0M | 43.6M | 50.0M | 68.8M |
Deferred Tax Liabilities | 0 | 1.2M | 2.3M | 2.2M | 1.7M |
Other Non-Current Liabilities | -1.0K | -2.0K | -1.0K | -2.0K | - |
Total Non-Current Liabilities | 220.0M | 140.8M | 62.4M | 69.4M | 89.7M |
Total Liabilities | 538.3M | 469.3M | 353.2M | 311.4M | 404.7M |
Equity | |||||
Common Stock | 54.2M | 54.2M | 54.2M | 54.2M | 54.2M |
Retained Earnings | - | 267.9M | 256.6M | 247.7M | 241.5M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 307.5M | 322.2M | 310.8M | 302.0M | 295.7M |
Key Metrics | |||||
Total Debt | 122.6M | 276.0M | 149.8M | 149.1M | 197.0M |
Working Capital | 311.3M | 324.7M | 303.0M | 290.7M | 291.1M |
Balance Sheet Composition
Centennial Surgical Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -16.2M | 12.7M | 14.6M | 10.7M | 15.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 16.1M | -59.2M | -61.4M | 69.5M | -26.3M |
Operating Cash Flow | 37.0M | -22.6M | -30.3M | 99.1M | 9.1M |
Investing Activities | |||||
Capital Expenditures | -114.7M | -77.0M | -1.6M | -1.6M | -8.4M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow | -114.7M | -77.0M | -1.6M | -1.7M | -8.4M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | 0 |
Debt Repayment | -21.9M | - | -16.6M | -29.7M | 0 |
Financing Cash Flow | -43.7M | 45.3M | -10.5M | -59.5M | 7.5M |
Free Cash Flow | 56.0M | -14.8M | 11.3M | 45.9M | 11.3M |
Net Change in Cash | -121.4M | -54.3M | -42.4M | 37.9M | 8.2M |
Cash Flow Trend
Centennial Surgical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
2,482.50
Price to Book
1.82
Price to Sales
1.04
Profitability Ratios
Profit Margin
-2.74%
Operating Margin
6.05%
Return on Equity
-4.65%
Return on Assets
1.53%
Financial Health
Current Ratio
1.98
Debt to Equity
108.97
Beta
0.49
Per Share Data
EPS (TTM)
₹-4.01
Book Value per Share
₹84.30
Revenue per Share
₹146.69
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
csurgsu | 558.2M | 2,482.50 | 1.82 | -4.65% | -2.74% | 108.97 |
Poly Medicure | 195.3B | 56.51 | 7.17 | 15.99% | 20.28% | 6.52 |
Dr Agarwal's Health | 140.4B | 625.56 | 7.45 | 6.61% | 4.88% | 49.87 |
Laxmi Dental | 21.8B | 64.42 | 10.33 | 25.70% | 13.29% | 9.35 |
Tarsons Products | 19.9B | 66.74 | 3.15 | 4.79% | 7.59% | 53.82 |
Prevest Denpro | 6.7B | 36.86 | 6.35 | 18.70% | 28.81% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.